About this Event
Managing Investigational Medicinal Products (IMPs) is a key part of clinical trial delivery and sponsor oversight.
YOU MUST USE YOUR ORGANISATION EMAIL TO REGISTER OTHEWISE TICKET WILL NOT BE ISSUED. APPROVAL IS SUBJECT TO ORGANISER'S REVIEW
This practical 2.5-hour HYBRID training session is aimed primarily at professionals working within academic sponsors, Clinical Trials Units (CTUs), CROs and research organisations who are involved in the management or oversight of IMPs.
The session will provide an introduction to the key regulatory, manufacturing and CMC considerations involved in managing IMPs within clinical trials, with a focus on their practical application.
Topics covered
- IMP manufacture – overview
- IMP regulations
- IMP sourcing and supplier/manufacturer oversight responsibilities
- CMC considerations
- Clinical Trial Application (CTA) documentation
The training will draw on practical examples and experience from clinical trial delivery, with opportunities for questions and discussion.
Who should attend?
The session may be particularly useful for those working in clinical trial management, regulatory affairs, quality, Ph*rm*cy, research governance and sponsor/CRO oversight roles.
Event venue & nearby stays
2nd Floor, Room 216. Maple House, 149 Tottenham Court Road, London, United Kingdom
Concerts, fests, parties, meetups — all the happenings, one place.